I think PBMs--this is a really interesting hearing, okay? But if you eliminate all the profitability and all the incentives for creating new drugs, you have not really made a dent in our health-care spend.
Senator Johnson emphasizes the importance of profitability in drug development amidst discussions on PBMs.
Share
More from Ron Johnson
This is going to take time, but when my staff saw this, I mean, to me, this immediately impacts public safety, immediately impacts informed consent.
That’s a 200,000-vote differential. That’s what ought to concern Tom Tiffany, and of course he’s not gonna run against Francesca Hong; he’s probably going to have a more formidable opponent.
So, you know, Bobby Kennedy has people in those agencies sabotaging his efforts at radical transparency.
Other voices in this conversation
